Significance of KDM6A mutation in bladder cancer immune escape

Abstract Background Bladder cancer (BC) is the fourth most prevalent neoplasm in men and is associated with high tumour recurrence rates, leading to major treatment challenges. Lysine-specific demethylase 6A (KDM6A) is frequently mutated in several cancer types; however, its effects on tumour progre...

Full description

Bibliographic Details
Main Authors: Xingxing Chen, Xuehua Lin, Guofu Pang, Jian Deng, Qun Xie, Zhengrong Zhang
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-08372-9
id doaj-6a19198397eb497786fe13a43bf95437
record_format Article
spelling doaj-6a19198397eb497786fe13a43bf954372021-05-30T11:49:25ZengBMCBMC Cancer1471-24072021-05-012111610.1186/s12885-021-08372-9Significance of KDM6A mutation in bladder cancer immune escapeXingxing Chen0Xuehua Lin1Guofu Pang2Jian Deng3Qun Xie4Zhengrong Zhang5Department of Urology, Zhuhai People’s Hospital, Zhuhai Hospital affiliated with Jinan UniversityDepartment of Urology, Zhuhai People’s Hospital, Zhuhai Hospital affiliated with Jinan UniversityDepartment of Urology, Zhuhai People’s Hospital, Zhuhai Hospital affiliated with Jinan UniversityDepartment of Urology, Zhuhai People’s Hospital, Zhuhai Hospital affiliated with Jinan UniversityDepartment of Urology, Zhuhai People’s Hospital, Zhuhai Hospital affiliated with Jinan UniversityDepartment of Urology, Zhuhai People’s Hospital, Zhuhai Hospital affiliated with Jinan UniversityAbstract Background Bladder cancer (BC) is the fourth most prevalent neoplasm in men and is associated with high tumour recurrence rates, leading to major treatment challenges. Lysine-specific demethylase 6A (KDM6A) is frequently mutated in several cancer types; however, its effects on tumour progression and clinical outcome in BC remain unclear. Here, we explored the potential role of KDM6A in regulating the antitumor immune response. Methods We mined The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases for somatic mutation and clinical data in patients with BC. Results We found frequent mutations in 12 genes in both cohorts, including TP53, KDM6A, CSMD3, MUC16, STAG2, PIK3CA, ARID1A, RB1, EP300, ERBB2, ERBB3, and FGFR3. The frequency o KDM6A mutations in the TCGA and ICGC datasets was 25.97 and 24.27%, respectively. In addition, KDM6A mutation was associated with a lower number of tumour-infiltrating immune cells (TIICs) and indicated a state of immune tolerance. KDM6A mutation was associated with lower KDM6A mRNA level compared with that in samples carrying the wild-type gene. Further, survival analysis showed that the prognosis of patients with low KDM6A expression was worse than that with high KDM6A expression. Using the CIBERSORT algorithm, Tumor Immune Estimation Resource site, and Gene Set Enrichment Analysis, we found that KDM6A mutation downregulated nine signalling pathways that participate in the immune system and attenuated the tumour immune response. Conclusion Overall, we conclude that KDM6A mutation is frequent in BC and promotes tumour immune escape, which may serve as a novel biomarker to predict the immune response.https://doi.org/10.1186/s12885-021-08372-9KDM6ABladder cancerMutationImmune
collection DOAJ
language English
format Article
sources DOAJ
author Xingxing Chen
Xuehua Lin
Guofu Pang
Jian Deng
Qun Xie
Zhengrong Zhang
spellingShingle Xingxing Chen
Xuehua Lin
Guofu Pang
Jian Deng
Qun Xie
Zhengrong Zhang
Significance of KDM6A mutation in bladder cancer immune escape
BMC Cancer
KDM6A
Bladder cancer
Mutation
Immune
author_facet Xingxing Chen
Xuehua Lin
Guofu Pang
Jian Deng
Qun Xie
Zhengrong Zhang
author_sort Xingxing Chen
title Significance of KDM6A mutation in bladder cancer immune escape
title_short Significance of KDM6A mutation in bladder cancer immune escape
title_full Significance of KDM6A mutation in bladder cancer immune escape
title_fullStr Significance of KDM6A mutation in bladder cancer immune escape
title_full_unstemmed Significance of KDM6A mutation in bladder cancer immune escape
title_sort significance of kdm6a mutation in bladder cancer immune escape
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2021-05-01
description Abstract Background Bladder cancer (BC) is the fourth most prevalent neoplasm in men and is associated with high tumour recurrence rates, leading to major treatment challenges. Lysine-specific demethylase 6A (KDM6A) is frequently mutated in several cancer types; however, its effects on tumour progression and clinical outcome in BC remain unclear. Here, we explored the potential role of KDM6A in regulating the antitumor immune response. Methods We mined The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases for somatic mutation and clinical data in patients with BC. Results We found frequent mutations in 12 genes in both cohorts, including TP53, KDM6A, CSMD3, MUC16, STAG2, PIK3CA, ARID1A, RB1, EP300, ERBB2, ERBB3, and FGFR3. The frequency o KDM6A mutations in the TCGA and ICGC datasets was 25.97 and 24.27%, respectively. In addition, KDM6A mutation was associated with a lower number of tumour-infiltrating immune cells (TIICs) and indicated a state of immune tolerance. KDM6A mutation was associated with lower KDM6A mRNA level compared with that in samples carrying the wild-type gene. Further, survival analysis showed that the prognosis of patients with low KDM6A expression was worse than that with high KDM6A expression. Using the CIBERSORT algorithm, Tumor Immune Estimation Resource site, and Gene Set Enrichment Analysis, we found that KDM6A mutation downregulated nine signalling pathways that participate in the immune system and attenuated the tumour immune response. Conclusion Overall, we conclude that KDM6A mutation is frequent in BC and promotes tumour immune escape, which may serve as a novel biomarker to predict the immune response.
topic KDM6A
Bladder cancer
Mutation
Immune
url https://doi.org/10.1186/s12885-021-08372-9
work_keys_str_mv AT xingxingchen significanceofkdm6amutationinbladdercancerimmuneescape
AT xuehualin significanceofkdm6amutationinbladdercancerimmuneescape
AT guofupang significanceofkdm6amutationinbladdercancerimmuneescape
AT jiandeng significanceofkdm6amutationinbladdercancerimmuneescape
AT qunxie significanceofkdm6amutationinbladdercancerimmuneescape
AT zhengrongzhang significanceofkdm6amutationinbladdercancerimmuneescape
_version_ 1721419927490920448